نتائج البحث - Helge Stenvold

  • يعرض 1 - 8 نتائج من 8
تنقيح النتائج
  1. 1
    Overexpression of the HIF Hydroxylases PHD1, PHD2, PHD3 and FIH Are Individually and Collectively Unfavorable Prognosticators for NSCLC Survival

    Overexpression of the HIF Hydroxylases PHD1, PHD2, PHD3 and FIH Are Individually and Collectively Unfavorable Prognosticators for NSCLC Survival حسب Sigve Andersen, Tom Dønnem, Helge Stenvold, Samer Al‐Saad, Khalid A. Alshibli, Lill‐Tove Busund, Roy M. Bremnes

    منشور في 2011
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    CD4/CD8 co-expression shows independent prognostic impact in resected non-small cell lung cancer patients treated with adjuvant radiotherapy

    CD4/CD8 co-expression shows independent prognostic impact in resected non-small cell lung cancer patients treated with adjuvant radiotherapy حسب Sigurd M. Hald, Roy M. Bremnes, Khalid Al‐Shibli, Samer Al‐Saad, Sigve Andersen, Helge Stenvold, Lill‐Tove Busund, Tom Dønnem

    منشور في 2013
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    The Role of Tumor-Infiltrating Immune Cells and Chronic Inflammation at the Tumor Site on Cancer Development, Progression, and Prognosis: Emphasis on Non-small Cell Lung Cancer

    The Role of Tumor-Infiltrating Immune Cells and Chronic Inflammation at the Tumor Site on Cancer Development, Progression, and Prognosis: Emphasis on Non-small Cell Lung Cancer حسب Roy M. Bremnes, Khalid Al‐Shibli, Tom Dønnem, Rafael Sirera, Samer Al‐Saad, Sigve Andersen, Helge Stenvold, Carlos Camps, Lill‐Tove Busund

    منشور في 2010
    احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Monocarboxylate Transporters 1–4 in NSCLC: MCT1 Is an Independent Prognostic Marker for Survival

    Monocarboxylate Transporters 1–4 in NSCLC: MCT1 Is an Independent Prognostic Marker for Survival حسب Marte Eilertsen, Sigve Andersen, Samer Al‐Saad, Yury Kiselev, Tom Dønnem, Helge Stenvold, Ingvild Pettersen, Khalid Al‐Shibli, Elin Richardsen, Lill‐Tove Busund, Roy M. Bremnes

    منشور في 2014
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Independent and tissue‐specific prognostic impact of miR‐126 in nonsmall cell lung cancer

    Independent and tissue‐specific prognostic impact of miR‐126 in nonsmall cell lung cancer حسب Tom Dønnem, Kenneth Lønvik, Katrine Eklo, Thomas Berg, Sveinung Wergeland Sørbye, Khalid Al‐Shibli, Samer Al‐Saad, Sigve Andersen, Helge Stenvold, Roy M. Bremnes, Lill‐Tove Busund

    منشور في 2011
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    MicroRNA Signatures in Tumor Tissue Related to Angiogenesis in Non-Small Cell Lung Cancer

    MicroRNA Signatures in Tumor Tissue Related to Angiogenesis in Non-Small Cell Lung Cancer حسب Tom Dønnem, Christopher G. Fenton, Kenneth Lønvik, Thomas Berg, Katrine Eklo, Sigve Andersen, Helge Stenvold, Khalid Al‐Shibli, Samer Al‐Saad, Roy M. Bremnes, Lill‐Tove Busund

    منشور في 2012
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Prognostic Impact of MiR-155 in Non-Small Cell Lung Cancer Evaluated by in Situ Hybridization

    Prognostic Impact of MiR-155 in Non-Small Cell Lung Cancer Evaluated by in Situ Hybridization حسب Tom Dønnem, Katrine Eklo, Thomas Berg, Sveinung Wergeland Sørbye, Kenneth Lønvik, Samer Al‐Saad, Khalid Al‐Shibli, Sigve Andersen, Helge Stenvold, Roy M. Bremnes, Lill‐Tove Busund

    منشور في 2011
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    Neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer (NORPACT-1): a multicentre, randomised, phase 2 trial

    Neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer (NORPACT-1): a multicentre, randomised, phase 2 trial حسب Knut Jørgen Labori, Svein Olav Bratlie, Bodil Andersson, Jon‐Helge Angelsen, Christina Biörserud, Bergþór Björnsson, Erling A. Bringeland, Nils Elander, Herish Garresori, Jon Erik Grønbech, Johan Haux, Oskar Hemmingsson, Maria Gustafsson Liljefors, Tor Åge Myklebust, Linn Såve Nymo, Katriina Peltola, Per Pfeiffer, Ville Sallinen, Per Sandström, Ernesto Sparrelid, Helge Stenvold, Kjetil Søreide, Bobby Tingstedt, Caroline S. Verbeke, Daniel Öhlund, Leif Klint, Svein Dueland, Kristoffer Lassen, Eirik Kjus Aahlin, Charlotte Bratthäll, Asif Halimi, Ingunn Hatlevoll, Margareta Heby, Arto Kokkola, Maximilian Kordes, Stina Lindblad, Linda Lundgren, Michael Bau Mortensen, Kim Erlend Mortensen, Jan Persson, Elena Rangelova, Elin Rønne, Oddvar M. Sandvik, Jon Arne Søreide, Caroline Vilhav, Kim Waardal, Johanna Wennerblom, Caroline Williamsson, Sheraz Yaqub

    منشور في 2024
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: